Dna Twopointo Inc.
Records under this name other than the patents Dna Twopointo Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 37 patents it holds.
Showing 1 to 8 of 8 · Back to Dna Twopointo Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,158,391 | Production of an alpha-carboxyl-omega-hydroxy fatty acid using a genetically modified Candida strain Formerly held In force · High confidence | In force | High confidence | |
| US 8,597,923 | Oxidation of compounds using genetically modified Candida Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,091,559 | Anti-ALK antibodies and methods for use thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,820,814 | Factor H Potentiating Antibodies and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,435,129 | Anti-Abeta Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 8,825,411 | Design, Synthesis and Assembly of Synthetic Nucleic Acids Lapsed on the fee record Ended Sep 2, 2026 · High confidence | Lapsed on the fee record | Ended Sep 2, 2026 | High confidence |
| US 8,635,029 | Systems and methods for biopolymer engineering Lapsed on the fee record Ended Jan 21, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 21, 2026 | From the USPTO record |
| US 8,412,461 | Systems and methods for antibody engineering Term ended Term ended Feb 7, 2025 · From the USPTO record | Term ended | Term ended Feb 7, 2025 | From the USPTO record |